Definitive Contract HHSD200201688483C
Award Date
12/18/15
Potential Completion Date
2/28/17
Potential Value
$310K
Federal Agency
CDC Pittsburgh
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $44,980,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the production and delivery of influenza vaccines. The contract, which does not have a set-aside designation, covers the 2017 adult flu season with a completion date of February 28, 2018. Seqirus, through its Seqirus USA, Inc. division, is a major supplier of influenza vaccines to various federal government...
This is a firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The contract, valued at $303,100.00, is for the delivery of adult flu vaccines during the 2016-2017 flu season. The contract does not have a set-aside designation. Seqirus USA Inc. is the prime contractor and has been awarded multiple Indefinite Delivery Contracts (IDCs) by the CDC, Department of...
This contract was awarded by the Centers for Disease Control and Prevention (CDC), an agency within the U.S. Department of Health and Human Services, to Seqirus USA Inc. through its Seqirus Usa, Inc. Division. The contract, valued at $23,480,000.00, is for the delivery of ADULT FLU vaccines. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the Ultimate Completion Date is February 28, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. is a...
This is a $58,485,000.00 definitive, firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) on December 23, 2016 to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The contract is for the delivery of pediatric influenza vaccines, with a period of performance ending on February 28, 2018. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal...
This is a $12,738,750.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in manufacturing influenza vaccines. The contract is for the delivery of influenza virus vaccines, with a period of performance ending on October 13, 2023. Seqirus USA Inc. is a global leader in influenza vaccine development, manufacturing, and delivery, and has been awarded numerous federal...
This is a $4,588,128.50 firm-fixed-price delivery order contract awarded to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines, by the Defense Logistics Agency's Medical Supply Chain. The contract is for the delivery of influenza virus vaccines and does not have a set-aside designation. Seqirus USA Inc. is a significant federal contractor, holding several large Indefinite Delivery Contracts (IDCs) with agencies like the Department of Veterans Affairs and Centers for...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Seqirus USA Inc., a global biotechnology company, for the provision of flu vaccines. The contract has a potential value of $138,880.00 and a completion date of October 31, 2018. Seqirus USA Inc., the prime contractor, is a foreign-owned, for-profit organization that manufactures influenza vaccines. The company has previously received contracts from various...
The Department of Veterans Affairs Veterans Health Administration awarded a Delivery Order to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods, to provide influenza vaccines for fiscal year 2018. The $157,143.00 firm fixed price contract did not have a set-aside designation. Seqirus USA Inc. is a division of Seqirus Usa, Inc., which has previously received awards from the Department of Defense, Department of Justice Bureau of Prisons, and Department of Health and Human...
This federal contract award, SPE2DP16M0735, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $124,772.50 firm-fixed-price purchase order is for the delivery of influenza virus vaccines, with an ultimate completion date of October 3, 2016. The contract does not have a set-aside designation. Seqirus USA Inc., through its Seqirus Usa, Inc. division, is known for producing a...
This is a firm-fixed-price delivery order awarded by the Federal Correctional Complex Butner, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods. The $3,102 contract is for the 2025 influenza virus vaccine program and has an ultimate completion date of September 30, 2025. Seqirus USA Inc. has been a registered federal contractor since 2008 and supplies influenza vaccines to various federal healthcare programs, including the Department of Veterans Affairs,...